{"title":"Development, function and maintenance of T lymphocyte populations in P-glycoprotein-deficient mice","authors":"Michael D. Eisenbraun Ph.D.","doi":"10.1016/S1529-1049(03)00006-0","DOIUrl":null,"url":null,"abstract":"<div><p>P-glycoproteins (P-gp) are widely known for their ability to pump drugs out of multidrug-resistant tumor cells, but are also normally expressed in a variety of nonmalignant tissues in mammals. In particular, lymphocytes and other hematopoietic cell lineages express P-gps during development and upon maturation in the periphery. However, the physiological significance of their expression in lymphocytes has been difficult to establish directly, although putative roles in cytotoxic function and cytokine release have previously been suggested. Progress toward resolving the actual nature of P-gp action in vivo has lately been aided by the production of P-gp-deficient mouse lines. Recent studies using these animals and data presented here indicate that P-gps are not required by peripheral T-lymphocytes for development or effector functions, but suggest they may have a role in the establishment or maintenance of certain T-cell population balances in the gut.</p></div>","PeriodicalId":89340,"journal":{"name":"Clinical and applied immunology reviews","volume":"4 1","pages":"Pages 49-58"},"PeriodicalIF":0.0000,"publicationDate":"2003-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1529-1049(03)00006-0","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and applied immunology reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1529104903000060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
P-glycoproteins (P-gp) are widely known for their ability to pump drugs out of multidrug-resistant tumor cells, but are also normally expressed in a variety of nonmalignant tissues in mammals. In particular, lymphocytes and other hematopoietic cell lineages express P-gps during development and upon maturation in the periphery. However, the physiological significance of their expression in lymphocytes has been difficult to establish directly, although putative roles in cytotoxic function and cytokine release have previously been suggested. Progress toward resolving the actual nature of P-gp action in vivo has lately been aided by the production of P-gp-deficient mouse lines. Recent studies using these animals and data presented here indicate that P-gps are not required by peripheral T-lymphocytes for development or effector functions, but suggest they may have a role in the establishment or maintenance of certain T-cell population balances in the gut.
p -糖蛋白(P-gp)因其将药物从多药耐药肿瘤细胞中泵出的能力而广为人知,但在哺乳动物的各种非恶性组织中也通常表达。特别是淋巴细胞和其他造血细胞系在发育和成熟时表达P-gps。然而,它们在淋巴细胞中表达的生理意义很难直接确定,尽管先前已经提出了它们在细胞毒性功能和细胞因子释放中的推测作用。解决体内P-gp作用的实际性质的进展最近得到了P-gp缺陷小鼠系的生产的帮助。最近使用这些动物的研究和本文提供的数据表明,P-gps不是外周t淋巴细胞发育或效应功能所必需的,但它们可能在肠道中某些t细胞群平衡的建立或维持中起作用。